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Edited by Vladimir SkulachevAbstract Metallothionein (MT) expression in carcinogenesis of
thyrocytes is unknown. We demonstrated that cadmium induced
transcription of all functional MT-1 and MT-2 isoforms and pro-
moted the cell cycle from the G1 to the S phase in thyroid cancer
cells, which can be suppressed by the ERK inhibitor. Cadmium
exposure stimulated intracellular calcium and the phosphoryla-
tion of ERK1/2. Therefore, a common pathway initiated by a
rapid rise in calcium and followed by calcium-mediated activa-
tion of ERK is involved in the transcriptional induction of func-
tional MT1 and MT2 isoforms and in the progression of the cell
cycle in thyroid cancer cells exposed to cadmium.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Metallothioneins (MTs) are a family of low molecular
weight, cysteine-rich, metal-binding proteins [1]. The precise
physiological role of MTs has not been fully elucidated. Pro-
posed roles include: (a) participation in maintaining the intra-
cellular homeostasis of essential transition metals, (b)
detoxiﬁcation of nonessential metals and (c) protection against
intracellular oxidative stress [2].
In mammals, there are four MTs: MT-1, MT-2, MT-3 and
MT-4. MT-1 and MT-2 are widely distributed in tissues while
MT-3 and MT-4 are more restricted in their distribution [3]. A
hallmark of the MT-1 and MT-2 genes is their rapid transcrip-
tion induced by transition metals such as cadmium, zinc and
copper [4]. In humans, MT-1 and MT-2 are encoded by a fam-
ily of genes located at 16q13 which consists of eight functionalAbbreviations: ARO, anaplastic thyroid carcinoma; Ca2+, calcium
ions; CaMK, calmodulin/calmodulin kinase; ERK, extracellular
signal-regulated kinase; ERK1/2, extracellular signal-regulated kinases
1 and 2; FBS, fetal bovine serum; MTF-1, metal transcription factor-1;
MTs, metallothioneins; MREs, metal-responsive elements; SDS,
sodium dodecyl sulfate
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doi:10.1016/j.febslet.2007.04.049(MT-1A, MT-1B, MT-1E, MT-1F, MT-1G, MT-1H, MT-1X,
and MT-2A) and seven nonfunctional (MT-1C, MT-1D, MT-
1I, MT-1J, MT-1K, MT-1L, and MT-2B) MT isoforms [5,6].
The induction of MT transcription by transition metals is med-
iated by regulatory elements, designated metal-responsive ele-
ments (MREs) [7], and by metal transcription factor-1
(MTF-1) which speciﬁcally binds to MREs [8]. However, to
date, there is a scarcity of knowledge regarding the signal path-
way involved in transition metal-induced MT transcription.
The extracellular signal-regulated kinase (ERK) pathway is
a signaling cascade that plays a critical role in gene expression,
especially genes involved in cell cycle progression, proliferation
and diﬀerentiation [9,10]. Calcium ions (Ca2+) are central to
many signal transduction pathways. It has recently been sug-
gested that activation of the ERK pathway results from an ele-
vation in intracellular Ca2+ [11,12]. In this study, we explored
the transcriptional induction of functional MT1 and MT2 iso-
forms and progression of the cell cycle induced by cadmium in
ARO cells, cells of an anaplastic thyroid carcinoma cell line.
Speciﬁcally, we investigated the role and relationship of Ca2+
and the ERK pathway to the transcription of functional
MT1 and MT2 isoforms induced by cadmium and to any
resulting progression of the cell cycle. Our results suggest that
MT-1A, -1F, -1G, -1H, -1X, and -2A are the main functional
MT1 and MT2 isoforms induced by cadmium in ARO cells
and that the cadmium-induced transcription of these func-
tional MT1 and MT2 isoforms is time-dependent. We ob-
served that cell cycle progression from the G1 to the S phase
accompanied the transcription of these functional MT1 and
MT2 isoforms induced by cadmium in ARO cells. We also
showed that the cadmium-induced transcription of these func-
tional MT1 and MT2 isoforms and progression of the cell
cycle were mediated by a rapid rise in Ca2+ followed by mod-
erate activation of ERK.2. Materials and methods
2.1. Cell culture
ARO cells were cultured in RPMI-1640 containing 10% fetal bovine
serum (FBS), 100 U/ml penicillin and 100 mg/ml streptomycin at 37 C
in a humidiﬁed atmosphere of 5% CO2/95% air. In order to induce
MT, ARO cells were exposed to cadmium (Sigma, St. Louis, MO) at
indicated concentrations for diﬀerent periods of time after they were
cultured in complete medium for 48 h and subsequently in serum-freeblished by Elsevier B.V. All rights reserved.
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ethane-N,N,N 0,N 0 tetraacetic acid (BAPTA) (Sigma) and the speciﬁc
ERK inhibitor PD98059 (Promega, Madison, WI) were used, these
two reagents were added 1 h prior to the exposure of the cells to cad-
mium.
2.2. Extract of total RNA and reverse transcription
Total RNA was isolated from exposed and non-exposed cells using
the RNeasy Mini Kit (QIAGEN, Hilden, Germany) according to the
manufacturer’s protocol. The concentration and purity of the ex-
tracted RNA was evaluated by spectrophotometric absorbance read-
ings at 260 and 280 nm. Total RNA (1 lg) was reverse-transcribed
using AMV reverse transcriptase (Promega) in 1· RT buﬀer [10 mM
Tris–HCl (pH 9.0), 50 mM KCl, and 0.1% Triton X-100], 20 U
RNase inhibitor, 1 mM dNTP mixture and 0.5 lg oligo dT(15) primer.
The sample mixtures were ﬁrst incubated at 42 C for 60 min, then at
94 C for 5 min and ﬁnally at 4 C for 5 min.
2.3. Primers for real-time PCR analysis of functional MT1 and MT2
isoforms
Primers for real-time PCR analysis of functional MT1 and MT2 iso-
forms were modiﬁed from Mididoddi and co-workers [13], and re-de-
signed based on the divergent 5 0 and 3 0 untranslated regions of each
MT isoform (Table 1). Primers for co-ampliﬁcation of the housekeep-
ing gene b-actin were designed based on the coding region of b-actin
(Table 1).
2.4. Real-time PCR analysis
Optimization of factors including MgCl2 concentration, cDNA con-
centration and the primer annealing temperature was carried out to
obtain speciﬁc real-time PCR ampliﬁcation. To ensure that both genesTable 1
Primer pairs for real-time PCR analysis of functional MT1 and MT2
isoforms
PCR product size
MT-1A
Forward 5 0-CTCGAAATGGACCCCAACT-30 219 bp
Reverse 5 0-ATATCTTCGAGCAGGGCTGTC-3 0
MT-1B
Forward 5 0-GCTTGTCTTGGCTCCACA-30 287 bp
Reverse 5 0-AGCAAACCGGTCAGGTAGTTA-3 0
MT-1E
Forward 5 0-ATCCTCTGGGTCTGGGTTCT-30 246 bp
Reverse 5 0-CAGGTTGTGCAGGTTGTTCTA-3 0
MT-1F
Forward 5 0-AGTCTCTCCTCGGCTTGC-30 232 bp
Reverse 5 0-ACATCTGGGAGAAAGGTTGTC-3 0
MT-1G
Forward 5 0-CTTCTCGCTTGGGAACTCTA-30 309 bp
Reverse 5 0-AGGGGTCAAGATTGTAGCAAA-3 0
MT-1H
Forward 5 0-CACCTCGGCTTGCAATGG-30 285 bp
Reverse 5 0-GCAAATGAGTCGGAGTTGTAG-3 0
MT-1X
Forward 5 0-TCTCCTTGCCTCGAAATGG-30 217 bp
Reverse 5 0-CACAGCTGTCCTGGCATCA-30
MT-2A
Forward 5 0-CCGACTCTAGCCGCCTCTT-30 259 bp
Reverse 5 0-GTGGAAGTCGCGTTCTTTACA-3 0
b-Actin
Forward 5 0-GATGAGATTGGCATGGCTTT-30 249 bp
Reverse 5 0-AGAGAAGTGGGGTGGCTTTT-30of the diﬀerent MT isoforms and b-actin were ampliﬁed at the same
eﬃciency by real-time PCR reaction, ampliﬁcation of several dilutions
of cDNA (0.1, 1, and 10 ng) was performed. PCR was performed using
ABI PRISM 7700 Sequence Detector (Applied Biosystems, Foster
City, CA) in a total reaction mixture of 25 ll containing 10 ng (opti-
mal) of cDNA of MT isoforms, 1· SYBR Green PCR Master Mix
(Applied Biosystems) and 200 nM of each primer. For the b-actin reac-
tion, 0.1 ng of cDNA was used. After activation of AmpliTaq Gold
DNA polymerase at 95 C for 5 min, the PCR cycle was started by
denaturation at 95 C for 15 s, followed by annealing and extension
at 60 C for 1 min. Relative quantiﬁcation was determined by the ratio
of the CT values of the target gene and that of b-actin [14]. The CT
value is taken as the fractional cycle number at which the emitted ﬂuo-
rescence of the sample passes a ﬁxed threshold above the baseline.
Higher ratios reﬂect a higher relative expression of the MT transcript.
2.5. Cell cycle analysis
The cell phase distribution was assayed by determination of the
DNA content. The cells were ﬁxed overnight in 5 ml of 70% ethanol
at 20 C. They were then washed with PBS and incubated with pro-
pidium iodide (20 lg/ml) and RNase A (200 lg/ml) in the dark for
30 min. The stained cell samples were subjected to ﬂow cytometry. A
DNA content frequency histogram was analyzed using deconvolution
software.
2.6. Determination of Ca2+
Ca2+ levels were monitored by Fluo-4/AM (Molecular Probes, Eu-
gene, OR) which is a Ca2+-sensitive ﬂuorescent indicator. ARO cells
were seeded at 8 · 105 cells/well in a 6-well plate and exposed to
20 lM of cadmium for diﬀerent periods of time. The cells were then
loaded with 5 lM of Fluo-4/AM in the dark at 37 C for 45 min. After
Fluo-4/AM treatment, the cells were harvested by trypsin and washed
with PBS. Following re-suspension in PBS, the cells were subjected to
ﬂow cytometry at an excitation wavelength of 488 nm and an emission
wavelength of 525 nm.
2.7. Western blot analysis of phosphorylated ERK1/2
50 lg of total protein from exposed and non-exposed cells was
loaded onto l2% sodium dodecyl sulfate (SDS)-polyacrylamide gels
and the separated proteins transferred to nitrocellulose membranes
(Amersham Biosciences, Piscataway, NJ). To detect the levels of p-
ERK1/2, a monoclonal anti-phospho speciﬁc antibody for ERK1/2
(Cell Signaling Technology, Beverly, MA) with a horseradish peroxi-
dase-conjugated goat-anti-mouse IgG antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA) was employed. A goat-anti-human b-actin
antibody (Santa Cruz Biotechnology) was used to detect the level of
b-actin, which was used as a control for equal loading. Detection of
the target protein signal was achieved by using an ECL system (Amer-
sham Biosciences).3. Statistical analysis
Data were expressed as means ± S.D. Statistical diﬀerence
was determined using two-way ANOVA and/or t-test. Signiﬁ-
cant diﬀerence existed when P < 0.05.4. Results
4.1. Functional MT1 and MT2 isoforms were induced by
cadmium in ARO cells
ARO cells were exposed to 20 lM of cadmium for 3, 6, 12,
24, 48 and 72 h and the mRNA levels of eight functional MT1
and MT2 isoforms were then detected using real-time PCR.
The mRNA levels of eight functional MT1 and MT2 isoforms
were increased in a time-dependent manner (Fig. 1). The in-
crease of MT-1B and MT-1E mRNA was much lower than
that of the other six MT isoforms. The results suggest that
MT-1A, MT-1F, MT-1G, MT-1H, MT-1X and MT-2A are
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Fig. 1. Transcriptional induction of functional MT1 and MT2 isoforms. ARO cells were cultured in complete medium for 48 h and then in serum-
free medium for a further 24 h. They were then exposed to 20 lM of cadmium for 3, 6, 12, 24, 48 and 72 h and the total RNA in the cells isolated. The
mRNA levels of functional MT1 (A–G) and MT2 (H) isoforms were detected by real-time PCR analysis and their levels were signiﬁcantly increased
in cells treated with cadmium compared with those without the treatment (P < 0.01, ANOVA). MT mRNA expression was normalized with b-actin.
The data represent a mean of three independent experiments.
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mium in ARO cells.
4.2. Alteration of cell cycle progression in ARO cells following
transcriptional induction of functional MT isoforms by
cadmium
To examine whether cadmium induced transcription of func-
tional MT1 and MT2 isoforms in ARO cells aﬀects the cell
phase distribution, the cell phase distribution was analyzed
by ﬂow cytometry. As shown in Fig. 2, exposure of ARO cells
to 20 lM of cadmium for 72 h resulted in an increase in the
proportion of cells in the S and G2-M phases and a decrease
in the proportion of cells in the G0/G1 phase. This result indi-cates that after inducing functional MT1 and MT2 isoforms,
cadmium exposure is able to promote cell cycle progression
from the G1 to the S phase and lead to an increase in the
G2–M phase.
4.3. In ARO cells exposed to cadmium, a rise in Ca2+ was
involved in the transcriptional induction of the main
functional MT1 and MT2 isoforms and the progression of
the cell cycle
To determine whether a calcium signal was involved in the
transcriptional induction of the main functional MT1 and
MT2 isoforms and the progression of the cell cycle in ARO
cells exposed to cadmium, the level of Ca2+ was analyzed by
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Fig. 2. Alteration of cell phase distribution. ARO cells were cultured in complete medium for 48 h and then in serum-free medium for a further 24 h.
After the cells were exposed to 20 lM of cadmium for 72 h, they were stained with propidium iodide (20 lg/ml) and RNase A for 30 min at room
temperature. The cell phase distribution of exposed and non-exposed cells was analyzed by ﬂow cytometry. The data represent a mean of three
independent experiments. **P < 0.01, compared with control.
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early as 0.5 h following their exposure to cadmium. A rise in
the level of Ca2+ could be signiﬁcantly inhibited by BAPTA,
a calcium chelator (Fig. 3A). To explore whether the transcrip-
tional induction of the main functional MT1 and MT2 iso-
forms and the progression of the cell cycle were related to an
increase in the level of Ca2+, ARO cells were pretreated with
BAPTA 1 h prior to their exposure to cadmium. The levels
of the main functional MT1 and MT2 isoforms were analyzed
by real-time PCR. As shown in Table 2, the levels of the main
functional MT1 and MT2 isoforms were close to those of the
control in cells treated with BAPTA. Furthermore, pretreat-
ment with BAPTA reduced the rise in the proportion of cad-
mium-exposed cells in the S and G2–M phases (Fig. 3B).
These data show that an increase in the level of Ca2+ in
ARO cells exposed to cadmium was involved in the transcrip-
tional induction of the main functional MT1 and MT2 iso-
forms and the progression of the cell cycle from the G1 to
the S phase.
4.4. Moderate activation of ERK1/2 was involved in the
transcriptional induction of the main functional MT1 and
MT2 isoforms and the progression of the cell cycle in ARO
cells exposed to cadmium
The activation of ERK was analyzed to determine whether
the ERK signal pathway was involved in the transcriptional
induction of the main functional MT1 and MT2 isoforms by
cadmium. The activation of ERK1/2 was assayed by Western
blot analysis using an antibody against phospho-ERK1/2.
The result showed that cadmium led to a moderate rise in
phosphorylated ERK1/2 (Fig. 4A). The eﬀect of moderate acti-
vation of ERK1/2 on the transcriptional induction of the main
functional MT1 and MT2 isoforms and the progression of the
cell cycle were investigated by using PD98059, an ERK1/2 spe-
ciﬁc inhibitor. As shown in Table 2, the levels of the main func-
tional MT1 and MT2 isoforms were signiﬁcantly reduced by
PD98059. Moreover, pretreatment with PD98059 reduced
the proportion of cells in the S and G2/M phases to a level low-
er than the control (Fig. 4C), suggesting that the ERK signal
plays an important role in the progression of the cell cycle
from the G1 to the S phase. These results indicate that the acti-
vation of ERK1/2 is involved in the transcriptional inductionof the main functional MT1 and MT2 isoforms and the pro-
gression of the cell cycle from the G1 to the S phase in the cells
exposed to cadmium. To examine whether a rise in Ca2+ was
related to a moderate activation of ERK1/2, BAPTA, a cal-
cium buﬀer, was used to block Ca2+ prior to cadmium expo-
sure. Western blot analysis showed that pretreatment with
BAPTA signiﬁcantly prevented the cadmium-induced phos-
phorylated ERK1/2 (Fig. 4B). This result suggests that a rise
in Ca2+ is necessary for the activation of ERK1/2 and that
ERK1/2 signaling is a downstream event following the increase
of Ca2+.5. Discussion
MT1 and MT2, unlike MT3 and MT4, are highly inducible
in mammalian cells by heavy metals such as cadmium. The
majority of studies using rodent animal models and cell lines
have demonstrated that the MT1 and MT2 isoforms-speciﬁc
genes are coordinately regulated by cadmium at the level of
transcription and that their functional isoforms are rapidly
inducible [3,4,15]. The assumption that these ﬁndings can be
extrapolated to human cells and tissues is called into question
by a gene duplication event that increases the number of MT1
genes and, as a result, the complexity of human MT gene orga-
nization [5,6]. An obvious regulatory alteration in human MT1
and MT2 expression is the loss of coordinate gene regulation
with numerous examples of inducer- and tissue-speciﬁc gene
expression. However, how MT1 and MT2 isoforms are regu-
lated by heavy metals in human thyroid carcinoma cells is un-
known. In our study, we demonstrated that all functional MT1
and MT2 isoforms could be signiﬁcantly induced by cadmium
in a time-dependent manner in anaplastic thyroid carcinoma
cells. However, the responses of these isoforms to cadmium
exposure were markedly diﬀerent at their transcriptional levels.
The transcriptional levels of MT-1B and MT-1E were much
lower than that of the other six MT isoforms, MT-1A, MT-
1F, MT-1G, MT-1H, MT-1X and MT-2A, suggesting that
these six MT isoforms are the main functional MT1 and
MT2 isoforms induced by cadmium in ARO cells. The tran-
scriptional induction of functional MT1 and MT2 isoforms
by cadmium may appear to be cell-type speciﬁc to anaplastic
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Fig. 3. Eﬀect of Ca2+ on the transcriptional induction of functional MT1 and MT2 isoforms and the cell phase distribution in cells exposed to
cadmium. ARO cells were cultured in complete medium for 48 h and then in serum-free medium for a further 24 h. The cells were exposed to 20 lM
of cadmium for 0.5, 1, 2 and 3 h. After exposure, the cells were stained with 5 lM Fluo-4 AM for 30 min at 37 C and analyzed by ﬂow cytometry
(A). The horizontal axis shows the relative ﬂuorescence intensity and the vertical axis cell numbers. Shaded areas are control cells without cadmium
exposure and open areas cadmium-exposed cells. In the experiment in which BAPTA was used to inhibit a rise in Ca2+, ARO cells were pretreated
with 100 lM BAPTA 1 h prior to their exposure to 20 lM of cadmium for 3 h. The shaded area is cadmium exposed cells and the open area
cadmium+BAPTA exposed cells. The results shown are representative of three independent experiments. In B, cell phase distribution of exposed and
non-exposed cells was analyzed by ﬂow cytometry. The data represent a mean of three independent experiments. **P < 0.01 and *P < 0.05, compared
with control; ++P < 0.01, and +P < 0.05, compared with cadmium-exposed cells.
Z.-M. Liu et al. / FEBS Letters 581 (2007) 2465–2472 2469thyroid carcinoma ARO cells when compared to other studies.
For instance, mRNA of MT-1A, MT-1E, MT-1X and MT-2A
is expressed in normal prostate tissue [16] and MT-1F, MT-1G
and MT-1H mRNA in breast myoepithelial cells [17]. MT-1A
and MT-1E isoforms are up-regulated after exposure to cad-
mium and zinc [18]. MT-1E, MT-1X and MT-2A isoformsare increased in PMC42 breast cancer cells and these cells
are resistant to copper and zinc toxicity [19]. Though most
types of cancers show an increase in MT expression [20], the
reduction of MT has been observed in several tumors. The le-
vel of MT is decreased in hepatic tumors [20] and human pap-
illary thyroid carcinoma cells display a loss of MT-1G isoform
Table 2
Relative levels of the main functional MT1 and MT2 isoform mRNA detected by real-time PCR
Control Cd BAPTA PD098059
MT-1A 0.0091 ± 0.0014 2.7502 ± 0.1365* 0.0721 ± 0.0093*# 0.5623 ± 0.0445*#
MT-1F 0.0057 ± 0.0006 5.3805 ± 0.5440* 0.2307 ± 0.0362*# 0.8332 ± 0.0692*#
MT-1G 0.0035 ± 0.0022 29.5190 ± 1.3890* 0.0134 ± 0.0006*# 0.9293 ± 0.1465*#
MT-1H 0.0024 ± 0.0002 2.9613 ± 0.0796* 0.0020 ± 0.0002*# 0.1393 ± 0.0162*#
MT-1X 0.0055 ± 0.0003 2.8000 ± 0.0944* 0.1293 ± 0.0101*# 0.2035 ± 0.0229*#
MT-2A 0.0351 ± 0.0018 30.4829 ± 0.8753* 0.6864 ± 0.0071*# 0.9256 ± 0.1494*#
The detail of real-time PCR procedure is described in Section 2. Cells were exposed to 20 lM of cadmium for 72 h or treated with 100 lMBAPTA or
40 lM of PD098059 for 1 h prior to their exposure to 20 lM of cadmium for 72 h.
*P < 0.01 compared with control.
#P < 0.01 compared with cadmium-exposed cells.
p-ERK1/2(44/42kDa)
β-actin 
control 3h 6h 12h 24h 48h 72h 
p-ERK1/2(44/42kDa)
β-actin 
control Cd
   Cd 
    + 
BAPTA
0
10
20
30
40
50
60
70
80
90
100
Pe
rc
en
ta
ge
 o
f c
e
lls
control
Cd
Cd+PD98059
**
**
**
**
**
**
**
*
++
++
++
+
G2/MG2/MSG0/G1
Fig. 4. Eﬀect of ERK1/2 activation on the transcriptional induction of functional MT1 and MT2 isoforms, the progression of the cell cycle and
activation of ERK1/2 in ARO cells exposed to cadmium. ARO cells were cultured in complete medium for 48 h and then in serum-free medium for a
further 24 h. The cells were exposed to 20 lM of cadmium for 3, 6, 12, 24, 48 and 72 h. The total protein of exposed and non-exposed cells was
extracted. The activation of ERK1/2 was determined by Western blot analysis using anti-phospho speciﬁc antibodies for p-ERK1/2 (A). In another
set of experiment, The activation of ERK1/2 was measured in the cells that were treated with 100 lM of BAPTA for 1 h prior to their exposure to
20 lM of cadmium for 6 h (B). The level of b-actin in the total protein was used as a control. In C, the cell phase distribution of exposed and non-
exposed cells was analyzed by ﬂow cytometry. The data represent a mean of three independent experiments. **P < 0.01 and *P < 0.05, compared with
control; ++P < 0.01, and +P < 0.05, compared with cadmium-exposed cells.
2470 Z.-M. Liu et al. / FEBS Letters 581 (2007) 2465–2472[21], both of which are thought to be due to the promoter
hypermethylation [20,21]. Thus diﬀerential MT expression pat-
terns may occur in diﬀerent types of cells that are exposed to
the same stimulus. We have noted that result of the MT-1Greduction in papillary thyroid carcinoma cells [21] is in con-
trast with the present data obtained in anaplastic thyroid car-
cinoma cells and also other studies [20,22]. The reason for this
apparent diﬀerence is unknown. However, the case of papillary
Z.-M. Liu et al. / FEBS Letters 581 (2007) 2465–2472 2471thyroid carcinoma samples is only 8 and the loss is found in 7
out 8 samples [21]. Obviously, a further study in a large num-
ber of samples is needed.
Growing evidence indicates that the cell cycle is regulated by
oncogenes and tumor suppressor genes, and that an alteration
of the cell cycle occurs in response to various carcinogens
[23,24]. Normal eukaryotic cells progress through a well-de-
ﬁned cell cycle consisting of four distinct phases: G1, S, G2,
and M. G1 and G2 phases are gaps installed into M-S phase
and S-M phase transitions respectively. These gaps allow for
the repair of damaged DNA and of replication errors. More-
over, G1 is a period when a variety of cell signals may inter-
vene and inﬂuence the fate of the cell [25]. Extracellular
factors such as metabolism, hypoxia and stress are integrated
and interpreted during this period. Faulty G1 control, caused
by the activation of a variety of oncogenes or by the inactiva-
tion of tumor suppressor genes, plays a critical role in tumor-
igenesis [25]. MTs are highly expressed in many types of
tumors and are involved in carcinogenesis. MT expression is
considered to be cell-cycle dependent and is used as a marker
of cell proliferation [26]. Generally speaking, the level of MT
is over expressed in most thyroid tumors [20,27], which is in
line with the present experiment. Therefore, it is thought that
the induction of functional MT1 and MT2 isoforms by cad-
mium can promote progression of the cell cycle in anaplastic
thyroid cancer cells. This assumption was tested in the present
study. We demonstrated that cadmium exposure led to an in-
crease in the proportion of cells in the S phase and G2–M
phase and a decrease in the proportion of cells in the G0/G1
phase after signiﬁcant induction of functional MT1 and MT2
isoforms. This result suggests that the induction of MTs may
inﬂuence the proliferation and growth of anaplastic thyroid
cancer cells by promoting the progression of the cell cycle from
the G1 phase to the S phase.
The ERK cascade is a central pathway that transmits signals
from many extracellular agents to regulate cellular processes
such as proliferation, diﬀerentiation and cell cycle progression.
The mechanism responsible for the transcriptional induction
of functional MT1 and MT2 isoforms and the progression of
the cell cycle by cadmium is not clear in thyroid cancer cells.
Since both ERK and MT are involved in the regulation of cell
cycle progression and proliferation, we wonder whether the
induction of functional MT1 and MT2 isoforms and the pro-
gression of the cell cycle by cadmium are regulated by ERK.
Our results show that the exposure of ARO cells to cadmium
results in the activation of ERK1/2 which occurs earlier than
both the signiﬁcant increase in the levels of the main functional
MT isoforms and the progression of the cell cycle. Therefore, it
appears that activation of ERK1/2 precedes the transcriptional
induction of MT1 and MT2 isoforms and the progression of
the cell cycle. The involvement of ERK1/2 in the regulation
of MT1 and MT2 isoform transcriptional induction and in
the progression of the cell cycle is further conﬁrmed by the
inhibitory experiment, in which PD98059, a speciﬁc inhibitor
of ERK, was used to block the activity of ERK. Pretreatment
of ARO cells with PD98059 signiﬁcantly inhibited a rise in
MT1 and MT2 isoform levels induced by cadmium and re-
duced the proportion of cells in the S and G2–M phases to
the control level. This ﬁnding clearly indicates that the ERK
pathway is involved in cadmium-induced transcription of the
MT gene and in cell cycle progression from the G1 to the S
phase in ARO cells. Signaling via the ERK cascade is mediatedby sequential phosphorylation and activation of protein ki-
nases in diﬀerent tiers of the cascade. Once activated ERK
has translocated to the nucleus, it stimulates gene transcription
by phosphorylation of transcription factors [22]. Metal tran-
scription factor-1 (MTF-1) plays a role in cadmium-induced
transcription of MT [28]. Therefore, it is possible that ERK
may activate MTF-1, which subsequently induces the expres-
sion of MT1 and MT2 isoforms.
Previous reports have shown that calcium is a potent inducer
of MT mRNA in EC3 cells, and that perturbation in cytosolic
calcium ion concentrations is involved in the signal transduc-
tion pathway governing MT gene expression [29]. Therefore,
we have explored whether calcium ions play a role in the
induction of functional MT1 and MT2 isoforms and in the
progression of the cell cycle in anaplastic thyroid carcinoma
cells, and also how this event is related to the activation of
ERK. We found that pretreatment of ARO cells with BAPTA,
a calcium chelator, signiﬁcantly prevented the elevation of the
main functional MT1 and MT2 isoforms. BAPAT also re-
duced the proportion of the S and G2–M phase cells induced
by cadmium and the expression of the isoforms to levels hat
were close to the control. This indicates that a rise in Ca2+ is
necessary for the transcriptional induction of MT1 and MT2
and the progression of the cell cycle in ARO cells exposed to
cadmium.
Having established the role of Ca2+ in the transcriptional
induction of the main functional MT1 and MT2 isoforms
and in the progression of the cell cycle in ARO cells, we start
to assess the relationship between calcium ions and the activa-
tion of ERK in the regulation of the transcription of MT1 and
MT2 isoforms and in the progression of the cell cycle. Our re-
sults showed that if a rise in the level of calcium ions was
blocked, activated ERK remained at the control level. There-
fore, the activation of ERK1/2 is dependent on a rise in
Ca2+ and is a downstream event to the calcium signal in cad-
mium-induced transcription of functional MT1 and MT2 iso-
forms and in the progression of the cell cycle in ARO cells. The
ﬁnding that an elevated ERK activity is subjected to calcium
ions in cadmium-induced transcription of functional MT1
and MT2 isoforms is not surprising. Firstly, calcium ions
can control the activity of the Ras/mitogen-activated protein
kinase MAPK1 which is involved in the activation of ERK
[30]. Secondly, the activity of ERK can be regulated by cal-
modulin/calmodulin kinase (CaMK) [31]. Thirdly, the Ca2+-
signaling mechanism, in terms of speed, amplitude and spa-
tio-temporal patterning, enables a rise in Ca2+ to rapidly reg-
ulate cellular events [32], which agrees with the rapid
regulatory action of Ca2+ seen in the present study.
In conclusion, our study demonstrates that MT-1A, -1F,
-1G, -1H, -1X and -2A are the main functional MT1 and
MT2 isoforms induced when anaplastic thyroid carcinoma
cells are exposed to cadmium. Transcriptional induction of
functional MT1 and MT2 isoforms by cadmium appears to
be cell-type speciﬁc. Accompanying the transcriptional induc-
tion of functional MT1 and MT2 isoforms in ARO cells ex-
posed to cadmium is the progression of the cell cycle from
the G1 to the S phase. This implies that transcriptional induc-
tion of functional MT1 and MT2 isoforms is involved in pro-
gression of the cell cycle. Cadmium exposure caused a rapid
rise in Ca2+ and moderate phosphorylation of ERK1/2. The
inhibition of ERK by PD98059 signiﬁcantly suppressed both
the transcription of functional MT1 and MT2 isoforms and
2472 Z.-M. Liu et al. / FEBS Letters 581 (2007) 2465–2472the progression of the cell cycle in ARO cells exposed to cad-
mium. Similarly, application of the calcium ion buﬀer BAPTA
inhibits the phosphorylation of ERK, suppresses the transcrip-
tional induction of functional MT1 and MT2 isoforms, and
block the progression of the cell cycle in ARO cells exposed
to cadmium. These results suggest that a common pathway,
initiated by a rapid rise in Ca2+ and followed by a calcium-
mediated activation of ERK, is involved in the transcriptional
induction of functional MT1 and MT2 isoforms with the sub-
sequent progression of the cell cycle from the G1 to the S phase
in ARO cells exposed to cadmium.
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